Mengrong Lei

机构：Central South University, PharmacoGenetics (China), Xiangya Hospital Central South University

发表论文 6 篇 · 总被引 29 次 · h-index 3

代表论文

• CircKIAA0182-YBX1 Axis: A Key Driver of Lung Cancer Progression and Chemoresistance (2025 · Cancer Letters · 被引 8)
• DPP Inhibition Enhances the Efficacy of PD-1 Blockade by Remodeling the Tumor Microenvironment in Lewis Lung Carcinoma Model (2024 · Biomolecules · 被引 7)
• Proteomic profiling of eIF3a conditional knockout mice (2023 · Frontiers in Molecular Biosciences · 被引 5)
• Design, synthesis and biological evaluation of coumarin-containing 2,4-diphenylpyrimidine derivatives as novel focal adhesion kinase inhibitors for treatment of non-small cell lung cancer (2025 · Bioorganic & Medicinal Chemistry Letters · 被引 3)
• Genetic Variants in Double-Strand Break Repair Pathway Genes to Predict Platinum-Based Chemotherapy Prognosis in Patients With Lung Cancer (2022 · Frontiers in Pharmacology · 被引 3)
• GWAS study of myelosuppression among NSCLC patients receiving platinum-based combination chemotherapy (2025 · Acta Biochimica et Biophysica Sinica · 被引 2)